Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10738313rdf:typepubmed:Citationlld:pubmed
pubmed-article:10738313lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:10738313lifeskim:mentionsumls-concept:C0850666lld:lifeskim
pubmed-article:10738313lifeskim:mentionsumls-concept:C0004358lld:lifeskim
pubmed-article:10738313lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:10738313pubmed:issue6lld:pubmed
pubmed-article:10738313pubmed:dateCreated2000-5-4lld:pubmed
pubmed-article:10738313pubmed:abstractTextIn recent studies a significant association between H. pylori infection and antigastric autoimmunity has been reported. Antigastric autoantibodies can be found in more than 30% of infected patients. Two distinct binding patterns of these autoantibodies have been described, first at the luminal membrane of the foveolar epithelium, and second at the canaliculi membranes of the parietal cells in the body mucosa. The latter type of autoantibodies correlates with histologic and clinical parameters of gastric mucosa atrophy. The gastric H,K-ATPase, which is known to be the autoimmune target in classical autoimmune gastritis, also represents a major autoantigen in atrophic H. pylori gastritis. Molecular mimicry between H. pylori and the host does not seem to be responsible for the generation of this type of autoreactivity. The development of antigastric autoantibodies may be a relevant host factor which contributes to the final clinical outcome of chronic H. pylori gastritis.lld:pubmed
pubmed-article:10738313pubmed:languageenglld:pubmed
pubmed-article:10738313pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10738313pubmed:citationSubsetIMlld:pubmed
pubmed-article:10738313pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10738313pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10738313pubmed:statusMEDLINElld:pubmed
pubmed-article:10738313pubmed:monthMarlld:pubmed
pubmed-article:10738313pubmed:issn1059-910Xlld:pubmed
pubmed-article:10738313pubmed:authorpubmed-author:KirchnerTTlld:pubmed
pubmed-article:10738313pubmed:authorpubmed-author:FallerGGlld:pubmed
pubmed-article:10738313pubmed:copyrightInfoCopyright 2000 Wiley-Liss, Inc.lld:pubmed
pubmed-article:10738313pubmed:issnTypePrintlld:pubmed
pubmed-article:10738313pubmed:day15lld:pubmed
pubmed-article:10738313pubmed:volume48lld:pubmed
pubmed-article:10738313pubmed:ownerNLMlld:pubmed
pubmed-article:10738313pubmed:authorsCompleteYlld:pubmed
pubmed-article:10738313pubmed:pagination321-6lld:pubmed
pubmed-article:10738313pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:10738313pubmed:meshHeadingpubmed-meshheading:10738313...lld:pubmed
pubmed-article:10738313pubmed:meshHeadingpubmed-meshheading:10738313...lld:pubmed
pubmed-article:10738313pubmed:meshHeadingpubmed-meshheading:10738313...lld:pubmed
pubmed-article:10738313pubmed:meshHeadingpubmed-meshheading:10738313...lld:pubmed
pubmed-article:10738313pubmed:meshHeadingpubmed-meshheading:10738313...lld:pubmed
pubmed-article:10738313pubmed:meshHeadingpubmed-meshheading:10738313...lld:pubmed
pubmed-article:10738313pubmed:meshHeadingpubmed-meshheading:10738313...lld:pubmed
pubmed-article:10738313pubmed:meshHeadingpubmed-meshheading:10738313...lld:pubmed
pubmed-article:10738313pubmed:year2000lld:pubmed
pubmed-article:10738313pubmed:articleTitleRole of antigastric autoantibodies in chronic Helicobacter pylori infection.lld:pubmed
pubmed-article:10738313pubmed:affiliationInstitute of Pathology, University of Erlangen-Nuremberg, Germany. Gerhard.Faller@patho.med.uni-erlangen.delld:pubmed
pubmed-article:10738313pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10738313pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10738313lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10738313lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10738313lld:pubmed